Videos Library

Successful evidence development for global launches

Related topics: MedTech, Market Access & HEOR

This free video is available for registered users


In today's demanding world of national requirements, how can companies develop the right evidence portfolio to succeed? How can they integrate evidence for payers with their regulatory studies?  This in depth review will discuss core principles in evidence development for diagnostics and therapeutic medical devices, and how these concepts can align with the requirements of the major global markets -- the UK, France, Germany, Japan and the USA. Learn about the evolving landscape of evidence demands in:

  • The UK, with NICE's development of new pathways for innovative devices
  • France's Forfeit Innovation and evidence demands
  • Germany's NUB evidence review requirements for high risk devices
  • Japan's emerging new pathways for breakthrough innovations
  • The US Medicare programs special coverage of FDA designated Breakthrough Devices

Stephen Hull

Principal and Founder
Hull Associates


Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.


This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.